US Broker Ratings

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 7.88% Potential Upside in the Organ Transplant Market

TransMedics Group, Inc. (NASDAQ: TMDX) stands out in the healthcare sector with its innovative approach to organ transplant technology. The Massachusetts-based company, with a market capitalization..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Biotech Powerhouse with 23% Potential Upside

For investors eyeing opportunities in the healthcare sector, BeOne Medicines Ltd. (ONC) presents a compelling case with its impressive market footprint and robust development pipeline. Specializing..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Healthcare Landscape with a Remarkable 52-Week Range

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands as a unique player in the healthcare sector, specifically within the realm of drug manufacturing specializing in traditional Chinese..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a Potential 31% Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical devices sector, presents a compelling case for investors seeking opportunities in the healthcare industry. With..

Corcept Therapeutics (CORT) Investor Outlook: A Promising 84% Upside Amidst Biotech Innovations

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is capturing attention with a significant potential upside of 84.09%, as indicated by analyst..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech with 24.98% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is capturing investor attention with its focus on developing innovative therapies for cancer patients. Headquartered in Cambridge, Massachusetts,..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Potential Upside with a Strong Dividend Yield

Fresenius Medical Care AG (NYSE: FMS), a prominent player in the healthcare sector, specializes in providing dialysis and related services to individuals with renal diseases. Headquartered..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unveiling a 16% Potential Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its compelling growth metrics and strategic partnerships. With a market capitalization of $7.63..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Uncovering a Potential 26.51% Upside in Biotechnology

TG Therapeutics, Inc. (NASDAQ: TGTX) has emerged as a notable player in the biotechnology sector, with its strategic focus on innovative treatments for B-cell mediated diseases...

Teleflex Incorporated (TFX) Stock Analysis: Navigating the Healthcare Sector with a 6.28% Potential Upside

Teleflex Incorporated (NYSE: TFX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Merit Medical Systems (MMSI): Investment Potential with 19.63% Upside and Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector specializing in medical instruments and supplies, is currently capturing the interest of investors..

Bruker Corporation (BRKR) Stock Analysis: Eyeing a 19.3% Upside Potential with Strong Buy Ratings

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing considerable attention from investors. As of now,..

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Innovator with 89.60% Revenue Growth and Strategic Partnerships

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, has been making waves with its cutting-edge solutions in health information services. The..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Potential Upside of 69% Amid Robust Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology industry, focusing on the development and commercialization of therapies for rare and life-threatening..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Leader with Robust Growth Prospects

Guardant Health, Inc. (NASDAQ: GH) stands out in the healthcare sector as a leading player in the diagnostics and research industry, particularly in the realm of..

AptarGroup, Inc. (ATR) Stock Analysis: Potential 41% Upside with Strong Buy Ratings

AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector’s medical instruments and supplies industry, is capturing investor attention with an enticing potential upside of..

Alcon Inc. (ALC) Stock Analysis: Exploring a 28.74% Potential Upside in Eye Care Innovation

Alcon Inc. (NYSE: ALC), a global leader in eye care products, is drawing attention from investors with its promising 28.74% potential upside, according to analyst ratings...

Sarepta Therapeutics (SRPT) Stock Analysis: A Biotech Player with a 68.40% Revenue Growth Surge

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, has captured considerable attention in the healthcare industry with its innovative approach to treating..

RadNet, Inc. (RDNT) Stock Analysis: Strong Buy Ratings Propel Investor Confidence Despite Valuation Challenges

RadNet, Inc. (NASDAQ: RDNT) is catching the attention of investors in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with Robust Revenue Growth and High ROE

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, operates within the medical distribution industry. With a market capitalization of $65.49 billion, it stands..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds